The delta variant of Covid-19 took the U.S. by surprise. Months after the first vaccines rolled out, Covid-19 infections surged as the delta variant overwhelmed the unvaccinated population and even broke through the immunity from the shots from Moderna, Pfizer and Johnson & Johnson. Now, the White House has a new plan to fight the delta variant, including booster shots and vaccine mandates. Here’s where we stand in the debate over booster shots, and in the fight against the delta variant.
Tag Archives: Pfizer
Covid-19: ‘The Rise Of The RNA Vaccines’ (Podcast)
Benjamin Thompson, Noah Baker and Elie Dolgin discuss RNA vaccines.
In this episode:
01:16 How RNA vaccines came to prominence
In less than a year, two RNA vaccines against COVID-19 were designed, tested and rolled out across the world. We discuss these vaccines’ pros and cons, how RNA technology lends itself to rapid vaccine development, and what this means for the fight against other diseases.
News feature: How COVID unlocked the power of RNA vaccines
09:20 The hurdles for trialling new COVID-19 vaccines
Multiple candidates for new COVID-19 vaccines are still being developed, which may offer advantages over the vaccines currently available. However, running placebo-controlled trials of these candidates is becoming increasingly difficult, so researchers are looking for different ways to evaluate them.
News: Search for better COVID vaccines confounded by existing rollouts
14:45 How long will COVID vaccines be effective?
There is much concern around the world about two faster-spreading variants of SARS-CoV-2. We get an update on whether these variants could render vaccines ineffective.
News: Could new COVID variants undermine vaccines? Labs scramble to find out
Covid-19: ‘How mRNA Vaccines Work’ (Video)
Messenger RNA—or mRNA—vaccines have been in development for decades, and are now approved for use against COVID-19. Here’s how they work and what you should know about them. Visit https://www.jhsph.edu/covid-19 for even more resources.
Covid-19 Infographic: Pfizer Vs Moderna
Morning News Podcast: FDA Approves Vaccine, States’ ICU Bed Shortages
NPR News Now reports: FDA votes to approve Pfizer/BioNTech vaccine, California stay-at-home orders, ICU beds in short supply and other top news.
Infographic: Top Covid-19 Vaccines ‘Cost Per Dose’
Covid-19: ‘When Will The U.S. Get The Vaccine?’
The initial doses of Pfizer and BioNTech’s Covid-19 vaccines could go out next month, if the FDA grants emergency authorization. There are also three other promising vaccine candidates in the pipeline from AstraZeneca, Moderna, and Johnson & Johnson. The process of distributing the vaccine to the 330 million people living in the U.S., however, could prove a logistical challenge. Here’s a look at how the federal government plans to do it.
World News: Covid-19 Vaccine, G-20 Summit
Radio News 24/7 reports: PFIZER AND BIONTECH apply for emergency Covid-19 vaccine authorization, G-20 meeting in Saudi Arabia, and other top world news.
Pfizer’s Covid-19 Vaccine Is 90% Effective, But Has Storage & Shipping Issues
Work to distribute Pfize and BioNTech’s COVID-19 vaccine is gearing up but it won’t hit local pharmacies for the general public any time soon.
Boomers Daily 